These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 17384318)

  • 1. Prevalence and impact of paratonia in Alzheimer disease in a multiracial sample.
    Vahia I; Cohen CI; Prehogan A; Memon Z
    Am J Geriatr Psychiatry; 2007 Apr; 15(4):351-3. PubMed ID: 17384318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioural and neuropsychological correlates of frontal lobe features in dementia.
    Engelborghs S; Maertens K; Mariën P; Vloeberghs E; Somers N; Nagels G; De Deyn PP
    Psychol Med; 2006 Aug; 36(8):1173-82. PubMed ID: 16700962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosing paratonia in the demented elderly: reliability and validity of the Paratonia Assessment Instrument (PAI).
    Hobbelen JS; Koopmans RT; Verhey FR; Habraken KM; de Bie RA
    Int Psychogeriatr; 2008 Aug; 20(4):840-52. PubMed ID: 18177542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitory paratonia and frontal lobe functioning.
    Beversdorf DQ; Heilman KM
    Neurology; 1998 Oct; 51(4):968-71. PubMed ID: 9781514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between a reduction in Frontal Assessment Battery scores and delusional thoughts in patients with Alzheimer's disease.
    Nagata T; Ishii K; Ito T; Aoki K; Ehara Y; Kada H; Furukawa H; Tsumura M; Shinagawa S; Kasahara H; Nakayama K
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):449-54. PubMed ID: 19460120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample.
    Marcus JF; Cellar JS; Ansari FP; Bliwise DL
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):801-5. PubMed ID: 17193340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy.
    Gainotti G; Ferraccioli M; Vita MG; Marra C
    J Int Neuropsychol Soc; 2008 Jul; 14(4):611-9. PubMed ID: 18577290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between saliva level of 3-methoxy-4-hydroxyphenylglycol and mental health in the elderly general population.
    Li GY; Watanabe I; Kunitake Y; Sugataka K; Muraoka T; Kojima N; Kawashima T; Yamada S
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):562-7. PubMed ID: 18950376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease.
    Geerlings MI; den Heijer T; Koudstaal PJ; Hofman A; Breteler MM
    Neurology; 2008 Apr; 70(15):1258-64. PubMed ID: 18391157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a German version of the Confusion Assessment Method for delirium detection in a sample of acute geriatric patients with a high prevalence of dementia.
    Hestermann U; Backenstrass M; Gekle I; Hack M; Mundt C; Oster P; Thomas C
    Psychopathology; 2009; 42(4):270-6. PubMed ID: 19521144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevalence and comorbidity of neuropsychiatric symptoms in Alzheimer's disease].
    García-Alberca JM; Pablo Lara J; González-Barón S; Barbancho MA; Porta D; Berthier M
    Actas Esp Psiquiatr; 2008; 36(5):265-70. PubMed ID: 18597200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary care screening for cognitive impairment in elderly veterans.
    Donnelly K; Donnelly JP; Cory E
    Am J Alzheimers Dis Other Demen; 2008; 23(3):218-26. PubMed ID: 18375531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychologic variables in sporadic late-onset Alzheimer disease in patients of spanish nationality: a fast and efficient assessment procedure.
    Sánchez JL; Rodríguez M; Carro J
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Sep; 15(3):207-15. PubMed ID: 12218714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The memory screening outreach program: findings from a large community-based sample of middle-aged and older adults.
    Crews WD; Harrison DW; Keiser AM; Kunze CM
    J Am Geriatr Soc; 2009 Sep; 57(9):1697-703. PubMed ID: 19694867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe Impairment Battery Language scale: a language-assessment tool for Alzheimer's disease patients.
    Ferris S; Ihl R; Robert P; Winblad B; Gatz G; Tennigkeit F; Gauthier S
    Alzheimers Dement; 2009 Sep; 5(5):375-9. PubMed ID: 19751916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of progression from mild cognitive impairment to Alzheimer disease.
    Palmer K; Berger AK; Monastero R; Winblad B; Bäckman L; Fratiglioni L
    Neurology; 2007 May; 68(19):1596-602. PubMed ID: 17485646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Executive dysfunction in Alzheimer disease.
    Swanberg MM; Tractenberg RE; Mohs R; Thal LJ; Cummings JL
    Arch Neurol; 2004 Apr; 61(4):556-60. PubMed ID: 15096405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.